Ensure Biologic Drug Safety with Flow Imaging Microscopy

Unlock Critical Insights into Subvisible Particles

Subvisible particles in biotherapeutics can impact safety, efficacy, and regulatory compliance. Traditional particle analysis methods often provide only particle sizing and count data, making it challenging to trace the source of particulates.

In this free white paper, discover how Flow Imaging Microscopy (FIM) offers a comprehensive, high-throughput solution to analyze subvisible particles in biologics by providing morphology data in addition to counts and sizing.

Learn how FIM:

✅ Enhances drug product safety and quality
✅ Detects, characterizes, and identifies API aggregates and contaminants in samples
✅ Provides richer data than light obscuration and other traditional methods
✅ Supports regulatory compliance

Download the white paper now to optimize your biologic drug development and ensure patient safety!